ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 78 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,072 | -85.2% | 22,560 | -81.7% | 0.00% | – |
| Q4 2022 | $183,442 | -46.1% | 122,964 | +9.9% | 0.00% | – |
| Q3 2022 | $340,031 | +0.6% | 111,844 | +9.1% | 0.00% | – |
| Q2 2022 | $338,146 | -1.5% | 102,481 | +45.0% | 0.00% | – |
| Q1 2022 | $343,231 | +246.7% | 70,682 | +453.4% | 0.00% | – |
| Q4 2021 | $99,000 | -80.0% | 12,772 | +8.9% | 0.00% | – |
| Q3 2021 | $495,000 | – | 11,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $28,947,000 | 30.22% |
| Foresite Capital Management V, LLC | 1,431,826 | $4,482,000 | 3.45% |
| Alphabet Inc. | 5,680,785 | $17,781,000 | 0.91% |
| 683 Capital Management, LLC | 3,390,000 | $10,610,000 | 0.82% |
| Slate Path Capital LP | 3,735,000 | $11,691,000 | 0.76% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $6,063,000 | 0.72% |
| Orbimed Advisors | 5,270,400 | $16,496,000 | 0.31% |
| Newtyn Management, LLC | 350,000 | $1,096,000 | 0.24% |
| Redmile Group, LLC | 1,920,960 | $6,013,000 | 0.23% |
| Oasis Management Co Ltd. | 348,432 | $1,091,000 | 0.18% |